TFA
PCRX icon

Toth Financial Advisory’s Pacira BioSciences PCRX Stock Holding History

Toth Financial Advisory’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,000
Closed -$309K – 969
2025
Q3 		$309K Buy
+12,000
New +$295K 0.03% 196
2024
Q3 		– Sell
-1,332
Closed -$38.1K – 762
2024
Q2 		$38.1K Hold
1,332
– – ﹤0.01% 319
2024
Q1 		$38.9K Sell
1,332
-10
-0.7% -$307 ﹤0.01% 315
2023
Q4 		$45.3K Sell
1,342
-355
-21% -$10.4K 0.01% 306
2023
Q3 		$52.1K Hold
1,697
– – 0.01% 265
2023
Q2 		$68K Hold
1,697
– – 0.01% 244
2023
Q1 		$69.3K Hold
1,697
– – 0.01% 250
2022
Q4 		$65.5K Sell
1,697
-125
-7% -$6.08K 0.01% 257
2022
Q3 		$97K Hold
1,822
– – 0.02% 216
2022
Q2 		$106K Sell
1,822
-11,550
-86% -$757K 0.02% 213
2022
Q1 		$1.02M Buy
13,372
+12,239
+1,080% +$816K 0.15% 115
2021
Q4 		$68K Hold
1,133
– – 0.01% 272
2021
Q3 		$63K Hold
1,133
– – 0.01% 283
2021
Q2 		$69K Sell
1,133
-17,715
-94% -$1.12M 0.01% 253
2021
Q1 		$1.32M Buy
18,848
+1,228
+7% +$87.7K 0.21% 92
2020
Q4 		$1.05M Buy
17,620
+2,855
+19% +$167K 0.18% 99
2020
Q3 		$888K Buy
14,765
+25
+0.2% +$1.45K 0.17% 102
2020
Q2 		$773K Buy
14,740
+12,890
+697% +$539K 0.17% 100
2020
Q1 		$62K Buy
+1,850
New +$76.9K 0.02% 168

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Toth Financial Advisory's PCRX Position: Q4 2025 in Review

Toth Financial Advisory sold out of Pacira BioSciences (PCRX) in Q4 2025, closing a stake of 12,000 shares — an estimated $309K sold.

Toth Financial Advisory first reported a position in PCRX in Q1 2020 and held it in 19 quarters. The position peaked at $1.32M in Q1 2021. 260 funds tracked by Wall St. Rank hold PCRX as of Q4 2025.

  • Toth Financial Advisory reported no remaining Pacira BioSciences position as of Q4 2025 after selling out during the quarter.
  • Toth Financial Advisory sold 12,000 Pacira BioSciences shares in Q4 2025, an estimated $309K.
  • Toth Financial Advisory first reported a position in Pacira BioSciences in Q1 2020 and held it in 19 quarters.
  • Toth Financial Advisory's Pacira BioSciences position peaked at $1.32M in Q1 2021.
  • 260 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2025.

Based on Toth Financial Advisory's 13F filing for Q4 2025, filed 20 Jan 2026.